Assessing the Impact of Comprehensive Medication Management on Achievement of the Quadruple Aim

Development of clinical pharmacy quality measures: A call to action

“…However, most of these studies were small, with significant design issues. In more recent years, however, stronger evidence from rigorous clinical trials has confirmed these findings of improved disease control and enhanced cost‐effectiveness of clinical pharmacy services 12 …”

“…The pharmacists' patient care process, the ACCP standards of practice for clinical pharmacists, and the patient care process for delivering comprehensive medication management (CMM) provide a structural framework within which pharmacists can provide standardized patient care services 14‐16 . Second, many metrics require compliance by health care providers and systems 12 . Some may be important in value‐based systems, whereas others may not.…”

Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic

“…It is impossible to keep in mind all the relevant interactions described, but knowledge of the main types of drugs most frequently involved in interactions can be crucial for establishing an alert system that contributes to improving prescription of drug therapy. Several methods that allow the reduction in the risks associated with interactions and thus improve the therapeutic risk/benefit ratio have been described, including among others the reduction in the number of drugs administered, avoiding unnecessary polymedication, the selection of alternative drugs with low AE rate, an adequate dosing regimen adjusted to the individualized characteristics of every patient, pharmacokinetic monitoring of serum concentrations of drugs in those cases in which this is possible and constant clinical observations in order to detect the consequences of an interaction as quickly as possible [ 62 , 63 , 64 , 65 ].…”

“Tele”‐ing the story of clinical pharmacy: Providing comprehensive medication management in a virtual environment

“…In addition, when evaluating the provision of CMM provided by a clinical pharmacist, only until recently have the core components of CMM been identified and standards for the philosophy of practice, practice management, and the CMM patient care process been solidified 6 . A recent review written primarily by American College of Clinical Pharmacy (ACCP) members highlighted the improvement of outcomes surrounding the quadruple aim of health care with pharmacists providing CMM 7 . This was one of the first reviews that tried to standardize and summarize articles related to a fidelity model of providing CMM tied to improvements in patient care outcomes.…”